TCRR Annual Total Long Term Liabilities
$3.32 M
-$19.97 M-85.76%
31 December 2022
Summary:
As of February 5, 2025, TCRR annual total long term liabilities is $3.32 million, with the most recent change of -$19.97 million (-85.76%) on December 31, 2022. During the last 3 years, it has risen by +$2.77 million (+507.33%).TCRR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRR Quarterly Long Term Liabilities
$2.71 M
-$606.00 K-18.28%
31 March 2023
Summary:
As of February 5, 2025, TCRR quarterly total long term liabilities is $2.71 million, with the most recent change of -$606.00 thousand (-18.28%) on March 31, 2023. Over the past year, it has dropped by -$34.35 million (-92.69%).TCRR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRR Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.8% | -92.7% |
| 3 y3 years | +507.3% | +364.8% |
| 5 y5 years | -93.0% | - |
TCRR Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -98.4% | -98.7% |
TCR2 Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.71 M(-18.3%) |
| Dec 2022 | $3.32 M(-85.8%) | $3.32 M(-91.2%) |
| Sept 2022 | - | $37.68 M(-12.8%) |
| June 2022 | - | $43.21 M(+16.6%) |
| Mar 2022 | - | $37.06 M(+59.1%) |
| Dec 2021 | $23.29 M(+2785.9%) | $23.29 M(-2.7%) |
| Sept 2021 | - | $23.93 M(-1.5%) |
| June 2021 | - | $24.30 M(-32.3%) |
| Mar 2021 | - | $35.90 M(+4348.9%) |
| Dec 2020 | $807.00 K | $807.00 K(+27.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $635.00 K(+4.3%) |
| June 2020 | - | $609.00 K(+4.5%) |
| Mar 2020 | - | $583.00 K(+6.8%) |
| Dec 2019 | $546.00 K(-99.7%) | $546.00 K(+15.2%) |
| Sept 2019 | - | $474.00 K(+2.2%) |
| June 2019 | - | $464.00 K(+2.0%) |
| Mar 2019 | - | $455.00 K(-99.8%) |
| Dec 2018 | $209.66 M(+344.8%) | $209.66 M(>+9900.0%) |
| Sept 2018 | - | $412.00 K(-99.1%) |
| Dec 2017 | $47.13 M(+61.6%) | $47.13 M |
| Dec 2016 | $29.17 M | - |
FAQ
- What is TCR2 Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual total long term liabilities year-on-year change?
- What is TCR2 Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly long term liabilities year-on-year change?
What is TCR2 Therapeutics annual total long term liabilities?
The current annual total long term liabilities of TCRR is $3.32 M
What is the all time high annual total long term liabilities for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual total long term liabilities is $209.66 M
What is TCR2 Therapeutics annual total long term liabilities year-on-year change?
Over the past year, TCRR annual total long term liabilities has changed by -$19.97 M (-85.76%)
What is TCR2 Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TCRR is $2.71 M
What is the all time high quarterly long term liabilities for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly total long term liabilities is $209.66 M
What is TCR2 Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TCRR quarterly total long term liabilities has changed by -$34.35 M (-92.69%)